DACVCP logo
Focused certification exam prep
Start practice

DACVCP Pass Rate 2026: What the Data Shows

TL;DR
  • No current DACVCP pass rate or fixed numerical pass mark could be verified from the American College of Veterinary Clinical Pharmacology's public pages.
  • The credential requires passing both Phase I (200 multiple-choice questions) and Phase II (ten question groups, 200 points) within a five-year window.
  • The 2026 administration was fully remote through ExamSoft: Phase I on May 19, Phase II on June 30.
  • Phase II eligibility requires two peer-reviewed papers accepted or published by February 1 of the examination year.

What Pass-Rate Data Actually Exists for the DACVCP

Candidates searching for a DACVCP pass rate usually want one number: the percentage of people who pass. Here is the honest position for the Diplomate, American College of Veterinary Clinical Pharmacology credential. The college's public pages describe the exam format, fees, eligibility rules, and administration details, but they do not publish a current pass rate, and a fixed numerical pass mark could not be verified either. Any site quoting a precise percentage for this credential is either guessing or importing a figure from another board that happens to share the same four-letter acronym.

That is not unusual for small specialty colleges. The ACVCP certifies a narrow population of veterinary clinical pharmacologists, most of whom arrive through approved residency training. Cohorts are small, which means year-to-year percentages would swing wildly on a handful of candidates and would say little about your individual odds. This article therefore does something more useful than repeating a number: it lays out the structural features of the exam that determine who passes, so you can judge your own readiness against the real mechanics. For a broader read on difficulty, see How Hard Is the DACVCP Exam? Complete Difficulty Guide 2026.

Data caution: No pass-rate percentage, cohort size, or first-attempt statistic is cited in this article because none could be verified from the issuer. Where the facts run out, the article says so rather than filling the gap with an estimate.

Why a Single Pass Rate Is the Wrong Question

The complete DACVCP credential requires both Phase I and Phase II. They test different things, they are scheduled on different dates, and they carry different eligibility gates. A blended "pass rate" would hide the fact that the two phases fail candidates for entirely different reasons.

FeaturePhase IPhase II
Format200 multiple-choice questions in two 100-question sessionsTen question groups worth 200 points across two 100-point sessions
Question typesMultiple choiceWritten responses, multiple choice, fill-in-the-blank, extended matching
Active exam timeEight hours, excluding the breakEight active hours in the ordinary schedule
2026 dateMay 19June 30
Delivery in 2026Remote, ExamSoftRemote, ExamSoft
Exam fee (2026 cycle)USD 200USD 300
Gate before sittingApplication with two references; residency enrollment or completionPhase I pass, credentials review, two peer-reviewed papers

Phase I is the breadth gate. Phase II is the depth gate, and it also demands scholarship in the form of published research. A candidate can be strong on one and exposed on the other, which is why the useful question is not "what percentage pass?" but "what does each phase reward, and where am I thin?" The detailed eligibility rules are covered in DACVCP Requirements 2026: Eligibility, Prerequisites & How to Qualify.

Phase I: Format and What a Pass Depends On

Phase I consists of 200 multiple-choice questions delivered in two 100-question sessions, ordinarily 08:00 to 12:00 and 14:00 to 18:00 local time. That is eight active hours with a midday break. The format rewards sustained accuracy across a very wide syllabus rather than depth in any single area.

The preparation headings preserved from the December 2021 suggested Phase I blueprint span the full breadth of veterinary clinical pharmacology: physiochemical characteristics of active pharmaceutical ingredients, pharmacodynamics, drug movement, pharmacokinetics, factors affecting drug movement and response, routes of administration, dosing forms and delivery devices, adverse events, and causes of therapeutic failure, followed by the organ-system and drug-class headings. These are dated preparation-curriculum topics rather than a verified current outline, so treat them as a strong study map, not a guarantee of exam content.

Why breadth matters for passing: With 200 multiple-choice items spread across more than twenty headings, no candidate can bank on strengths alone. Weak coverage in even three or four headings, such as botanicals or disinfectants and antiseptics, can erode a margin built elsewhere. The mechanical lesson is to close gaps before polishing strengths.

The remote delivery layer

For the 2026 administration, the college published remote delivery through ExamSoft. Candidates supply a compatible Windows or Mac laptop running Examplify with administrator privileges. Encrypted exam files are downloaded in advance and unlocked with a proctor password; once in examination mode, the software blocks internet access, files, and other applications. The college offers advance practice examinations so candidates can rehearse the software and become familiar with question structure. Treat this as a genuine risk-reduction step: technical surprises on exam day are a preventable way to lose composure across an eight-hour day.

Phase II: Ten Question Groups, 200 Points

Phase II is structured differently and should not be mentally filed as "Phase I again." It has ten question groups mixing written responses, multiple choice, fill-in-the-blank, and extended matching, worth 200 points across two 100-point sessions. The point total is not a question count, so you cannot translate it into a number of items to answer correctly. The ordinary schedule provides eight active hours.

The four examination subject categories listed on the current Phase II page are:

  • Therapeutics
  • Pharmacokinetics and Therapeutic Drug Monitoring
  • Experimental Design, Statistics and Analytical Methods
  • Regulatory Pharmacology

The college does not publish current percentage weights for these categories. A separately indexed December 2021 Phase II blueprint contains historical question allocations, but those are not converted here into current percentages and should not be treated as the present ten-group, 200-point layout.

Why Phase II rewards applied thinking

Written-response and extended-matching formats reward candidates who can construct an argument, not just recognize a correct option.

  • Expect to justify dosing or monitoring decisions in your own words.
  • Expect statistical and design questions that test whether you can critique a study, not merely define terms.
  • Expect regulatory questions that connect pharmacology to the framework governing veterinary drugs.

Because the four categories overlap with the real work of a clinical pharmacologist, candidates whose residency gave them hands-on exposure to study design and regulatory submissions tend to have a natural advantage. Those whose training was clinically focused should deliberately build fluency in statistics and analytical methods. The category-level map is expanded in DACVCP Exam Domains 2026: Complete Guide to All 26 Content Areas.

How the Pass Mark Is Set

Candidates often ask for the exact score needed. The public record says only that passing points are recommended by the Examination Committee and ad hoc reviewers for Board approval. No fixed numerical pass mark was verified. That process language matters because it implies a deliberate, committee-reviewed standard rather than a simple cut at a round number, and it means you should not plan around a rumored percentage.

The practical consequence is that you cannot reverse-engineer a "safe" score and study to it. The sound strategy is to aim for consistent competence across every heading and to treat the pass decision as a judgment about overall readiness. Our companion piece DACVCP Passing Score 2026: Exactly What You Need to Pass tracks what is and is not publicly established.

Key Takeaway

Do not anchor on a rumored percentage. Because the pass standard is committee-recommended and Board-approved rather than published as a fixed number, the only reliable preparation target is demonstrated competence across every domain.

Where Candidates Are Lost Before They Sit

For a credential like this, a meaningful share of the difficulty is front-loaded into eligibility. You can only attempt the exam if you clear several gates, and each one is a place where timelines slip.

Phase I gate

Applicants must be legally qualified to practice veterinary medicine and be enrolled in or have completed approved ACVCP residency training. The application requires two references. Applications are ordinarily due October 1 before the examination year, with intent to sit due by February 1; the currently dated checklist covers October 1, 2025 and February 1, 2026.

Phase II gate

Phase II requires completed approved training, a Phase I pass, approved credentials, course documentation and transcripts, and two peer-reviewed papers accepted or published by February 1 of the examination year. At least one paper must be original veterinary clinical pharmacology research; the other may be original research or an eligible evidence-based systematic review or meta-analysis. At least one must list you as first author. Neither paper may have been used for another specialty board, and publication must not predate the beginning of training by more than two years.

The publication bottleneck: The two-paper requirement is a calendar problem as much as a scholarship problem. Peer review timelines are outside your control, so a manuscript submitted late in training can miss the February 1 deadline and push your Phase II attempt back a full year. Start the research pipeline early, long before exam preparation intensifies.

These gates mean the population that actually sits the exam is already filtered by training completion and scholarship. It also means that "failing to qualify" is a distinct risk from "failing the exam," and one that careful planning can largely eliminate.

Domains Where Candidates Most Need Margin

Without published domain-level failure data, any claim about which areas candidates fail most would be speculation. What can be said is which areas are structurally easy to under-prepare, based on how the syllabus is built.

Domain 1: Physiochemical characteristics of active pharmaceutical ingredients

This is the foundation that explains absorption, distribution, and formulation behavior, and it is easy to neglect once you are deep in clinical rotations.

  • Revisit ionization, lipophilicity, and solubility concepts and how they drive membrane transport.
  • Connect chemistry to dosing-form selection and stability.

Domains 3 and 4: Drug movement and Pharmacokinetics

These carry the quantitative load. Expect to reason through compartmental behavior, clearance, volume of distribution, and half-life rather than recall definitions.

  • Practice interpreting concentration-time data, not just reciting equations.
  • Link these directly to Domain 24 on therapeutic drug monitoring for Phase II.

Domains 21 and 22: Botanical/Herbals and Disinfectants/antiseptics

These are low-profile headings that appear on the preparation list precisely because they are easy to skip. A candidate who ignores them concedes avoidable points on a breadth-driven Phase I.

  • Know the pharmacologic rationale, safety concerns, and interaction risks for commonly used botanicals.
  • Understand spectrum, mechanism, and appropriate use of common antiseptic and disinfectant classes.

Domain 25: Experimental Design, Statistics and Analytical Methods

This Phase II category is where clinically trained candidates often feel least anchored. It rewards the ability to evaluate a study design and interpret analytical results critically.

  • Be comfortable with study design choices, bias, power, and appropriate statistical tests.
  • Understand analytical method validation concepts relevant to drug concentration assays.

If you want the full 26-heading breakdown tied to organ systems and drug classes, from the nervous system through anti-infectives, the complete domains guide walks through each one, and a condensed reference lives in the DACVCP Cheat Sheet 2026: One-Page Review of Must-Know Facts.

Fees, Retakes, and the Five-Year Window

Pass-rate thinking is incomplete without understanding what a failed attempt costs, because that shapes how aggressively to sequence your attempts.

Item (2026 cycle)Published amount
Phase I applicationUSD 75
Phase I examinationUSD 200
Phase II credentials reviewUSD 250
Phase II examinationUSD 300

Retakes require payment of the respective examination fee. The general fee page permits refunds only for extenuating circumstances accepted by the Board, while the individual phase pages describe examination fees as nonrefundable, so budget on the assumption that a fee, once paid, is gone. A separate page calls USD 75 a first-year candidate registration fee; the public pages do not establish whether this duplicates or adds to the Phase I application charge, so confirm directly with the college rather than assuming either. For a full cost picture beyond these exam fees, see DACVCP Certification Cost 2026: Complete Pricing Breakdown.

The five-year clock

Both phases must be passed within a five-year eligibility period that begins with the first eligible examination year after Phase I approval. The issuer's example: Phase I approval in December 2025 permits the 2026 through 2030 examinations. This is an examination-eligibility window, not credential renewal. Its effect on strategy is significant: a failed attempt does not end your path, but the window caps how many annual opportunities you have, so each attempt should be taken seriously rather than treated as a trial run.

Sequencing Preparation Around the Domains

This is the one place for study structure, and it is tied to the actual domain list. The logic is to build from chemistry and mechanisms outward, then layer on the applied Phase II categories.

Block 1

Foundations

  • Domains 1 to 4: physiochemical properties, pharmacodynamics, drug movement, pharmacokinetics.
  • Why first: every later organ-system and drug-class topic depends on these principles.
Block 2

Variability and failure

  • Domains 5 to 9: factors affecting response, routes, dosing forms, adverse events, therapeutic failure.
  • Why here: these convert foundations into clinical reasoning about why drugs behave differently.
Block 3

Organ systems and drug classes

  • Domains 10 to 22: nervous, renal, cardiovascular, gastrointestinal, reproduction, endocrine, senses, inflammation, anticancer, fluids, anti-infectives, botanicals, disinfectants.
  • Schedule the neglected headings, 21 and 22, deliberately rather than leaving them for last.
Block 4

Phase II applied categories

  • Domains 23 to 26: therapeutics, pharmacokinetics and therapeutic drug monitoring, experimental design and statistics, regulatory pharmacology.
  • Practice written justification, not just recognition.

Because Phase I and Phase II are separated by weeks and by a pass requirement, many candidates run Blocks 1 to 3 before Phase I and revisit Block 4 afterward. A fuller week-by-week approach is in the DACVCP Study Guide 2026: How to Pass on Your First Attempt, and you can pressure-test recall with questions at the main practice test site.

Who Hires Diplomates and Why It Matters

Understanding where the credential leads clarifies why the exam is built the way it is. Veterinary clinical pharmacologists typically work in academia, where they teach, run research programs, and operate clinical pharmacology services; in the pharmaceutical and animal-health industry, where drug development and regulatory work draw heavily on the experimental design and regulatory categories; and in regulatory or government settings concerned with veterinary drug approval and safety. The Phase II categories of experimental design, statistics, and regulatory pharmacology mirror these career paths directly.

For the earnings and career picture, see DACVCP Salary Guide 2026: Complete Earnings Analysis, and for the value judgment, Is the DACVCP Certification Worth It? Complete ROI Analysis 2026. For role listings and employer types, DACVCP Jobs collects the details.

Key Takeaway

Treat the pass rate as a planning input, not a prediction. Since it is unpublished, your best control lever is eligibility timing: secure your two papers and meet the October 1 and February 1 deadlines first, then spend your remaining effort on domain breadth.

Maintenance after you pass

Passing is not the end of the credential's administrative life. A Maintenance of Certification committee administers recertification, according to the college's current Committees page. Historical bylaws approved in June 2018 describe review of maintenance records every two years toward maintenance at ten years, but the complete legacy file could not be retrieved and its current applicability remains unverified. No current renewal hours, fees, or interval should be inferred from that historical text; confirm the present requirements with the college.

Frequently Asked Questions

What is the DACVCP pass rate?

No current pass rate is published on the ACVCP's public pages, and none could be verified. Cohorts are small, so year-to-year percentages would be unstable anyway. Be skeptical of any site quoting a precise figure for this specific credential.

What score do I need to pass the DACVCP exam?

A fixed numerical pass mark was not verified. Passing points are recommended by the Examination Committee and ad hoc reviewers and approved by the Board. Prepare for competence across all domains rather than a target percentage.

Do I have to pass both phases?

Yes. The complete credential requires Phase I and Phase II, and both must be passed within the five-year eligibility period that begins with the first eligible examination year after Phase I approval.

Can I retake the exam if I fail?

Retakes are possible within your five-year window and require the respective examination fee again. The phase pages describe examination fees as nonrefundable, so plan each attempt as a real one.

When is the next DACVCP exam?

The published 2026 administration was Phase I on May 19 and Phase II on June 30, both remote via ExamSoft, and those dates have passed. A 2027 schedule was not verified, so check the college's Candidate Information page. See DACVCP Exam Dates 2026: Testing Windows, Deadlines & Scheduling for deadline details.

For background on the credential itself, start with What Is DACVCP?, and when you are ready to test your recall, try the questions at the practice test hub.

Ready to pass your DACVCP exam?

Put this into practice with free DACVCP questions across every exam domain.